Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—General
5.03% $9.73
America/New_York / 3 mai 2024 @ 09:30
FUNDAMENTALS | |
---|---|
MarketCap: | 3 536.11 mill |
EPS: | 0.480 |
P/E: | 20.26 |
Earnings Date: | May 09, 2024 |
SharesOutstanding: | 363.57 mill |
Avg Daily Volume: | 0.0000 mill |
RATING 2024-05-03 |
---|
A- |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Buy | |
Return On Asset: | Buy | |
DE: | Neutral | |
P/E: | Neutral | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.70x |
Company: PE 20.26 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.49x |
Company: PE 20.26 | industry: PE 41.65 |
DISCOUNTED CASH FLOW VALUE |
---|
$11.66 (19.86%) $1.932 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
$ 9.60 - 9.86 ( +/- 1.36%) |
ATR Model: 14 days |